Helmers Sevim Barbasso, Jiang Xia, Pettersson David, Wikman Anna-Lis, Axelman Pia, Lundberg Åsa, Lundberg Ingrid E, Alfredsson Lars
Unit of Cardiovascular Epidemiology , Karolinska Institutet, Institute of Environmental Medicine , Stockholm , Sweden.
Department of Medicine, Rheumatology Unit , Karolinska Institutet, Karolinska University Hospital , Stockholm , Sweden.
RMD Open. 2016 Dec 26;2(2):e000342. doi: 10.1136/rmdopen-2016-000342. eCollection 2016.
To assess the association between inflammatory lung disease and the risk of developing idiopathic inflammatory myopathies.
A population-based case-control study was conducted. Adult myositis cases, identified from the Swedish inpatient registry (diagnosed between 1995 and 1997), and randomly selected controls matched to cases on the date of birth, gender and residency, were asked to fill out a questionnaire with questions on lifestyle, environmental exposures and health. Eventually, 100 cases and 402 controls responded to the questionnaire and were included in the analyses. Exposure was defined as self-reported preceding inflammatory lung diseases (pneumonia, tuberculosis or sarcoidosis). The association between the exposure and risk of developing myositis was evaluated by calculating OR together with 95% CIs in logistic regressions.
42 (42%) cases and 112 (28%) controls reported preceding inflammatory lung disease. Median duration between inflammatory lung disease and first symptom of myositis was 30 years. We observed a significant association between self-reported history of lung disease at study inclusion and diagnosis of myositis (crude OR=1.8 (1.1 to 2.9); smoking adjusted OR=1.9 (1.2 to 3.1)). We further identified a modestly increased, yet non-significant, association between preceding inflammatory lung disease (prior to index year) and diagnosis of myositis (smoking adjusted OR=1.6 (0.9 to 2.8)). The association was more pronounced among the cases of myositis with concurrent interstitial lung disease (OR=3.8 (1.0 to 14.5)).
Patients with preceding inflammatory lung disease tend to have an increased risk of developing myositis compared to those without. The effect was more pronounced among patients with myositis with concurrent interstitial lung disease. Thus inflammatory lung disease may constitute a risk factor for myositis.
评估炎症性肺病与特发性炎症性肌病发病风险之间的关联。
开展一项基于人群的病例对照研究。从瑞典住院患者登记系统中识别出成年肌炎病例(诊断时间为1995年至1997年),并随机选取在出生日期、性别和居住地方面与病例匹配的对照,要求他们填写一份关于生活方式、环境暴露和健康状况的问卷。最终,100例病例和402名对照对问卷做出回应并纳入分析。暴露定义为自我报告的既往炎症性肺病(肺炎、肺结核或结节病)。通过在逻辑回归中计算比值比(OR)及95%可信区间(CI)来评估暴露与肌炎发病风险之间的关联。
42例(42%)病例和112名(28%)对照报告有既往炎症性肺病。炎症性肺病与肌炎首发症状之间的中位间隔时间为30年。我们观察到在研究纳入时自我报告的肺部疾病史与肌炎诊断之间存在显著关联(粗OR = 1.8(1.1至2.9);调整吸烟因素后的OR = 1.9(1.2至3.1))。我们进一步发现既往炎症性肺病(在索引年份之前)与肌炎诊断之间存在适度增加但不显著的关联(调整吸烟因素后的OR = 1.6(0.9至2.8))。这种关联在合并间质性肺病的肌炎病例中更为明显(OR = 3.8(1.0至14.5))。
与无既往炎症性肺病的患者相比,有既往炎症性肺病的患者患肌炎的风险往往增加。这种影响在合并间质性肺病的肌炎患者中更为明显。因此,炎症性肺病可能是肌炎的一个危险因素。